BlackDiamond Wealth Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,172
Closed -$237K 140
2023
Q3
$237K Buy
18,172
+1,177
+7% +$18.3K 0.21% 107
2023
Q2
$274K Buy
16,995
+344
+2% +$5.61K 0.23% 101
2023
Q1
$272K Buy
16,651
+959
+6% +$15.4K 0.28% 88
2022
Q4
$252K Buy
15,692
+140
+0.9% +$2.17K 0.29% 87
2022
Q3
$236K Buy
15,552
+635
+4% +$10.5K 0.28% 91
2022
Q2
$256K Buy
+14,917
New +$256K 0.32% 89

Other funds holding BMEZ

BlackDiamond Wealth Management's BMEZ Position: Q4 2023 in Review

BlackDiamond Wealth Management sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2023, closing a stake of 18,172 shares — an estimated $237K sold.

BlackDiamond Wealth Management first reported a position in BMEZ in Q2 2022 and held it in 6 quarters. The position peaked at $274K in Q2 2023. 105 funds tracked by Wall St. Rank hold BMEZ as of Q4 2023.

  • BlackDiamond Wealth Management reported no remaining BlackRock Health Sciences Trust II position as of Q4 2023 after selling out during the quarter.
  • BlackDiamond Wealth Management sold 18,172 BlackRock Health Sciences Trust II shares in Q4 2023, an estimated $237K.
  • BlackDiamond Wealth Management first reported a position in BlackRock Health Sciences Trust II in Q2 2022 and held it in 6 quarters.
  • BlackDiamond Wealth Management's BlackRock Health Sciences Trust II position peaked at $274K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2023.

Based on BlackDiamond Wealth Management's 13F filing for Q4 2023, filed 9 Feb 2024.